Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.004 Å; R factor = 0.042; wR factor = 0.105; data-to-parameter ratio = 16.3.
Related literature
For the structure of a similar compound, 4-(benzo[d]thiazol-2-yl)-2-allyl-3-methyl-1-phenyl-1,2-dihydropyrazol-5-one, see: Chakibe et al. (2010) . For the structure of a related compound, (E)-4-(2,3-dihydro-1,3-benzothiazol-2-ylidene)-3-methyl-1phenyl-1H-pyrazol-5(4H)-one, see: Chakib et al. (2010) .
Experimental
Crystal data C 20 H 15 N 3 OS M r = 345.41 Orthorhombic, P2 1 2 1 2 1 a = 4.8221 (1) Å b = 9.3698 (2) Å c = 37.6990 (9) Å V = 1703.32 (6) Å 3 Z = 4 Mo K radiation = 0.20 mm À1 T = 293 K 0.40 Â 0.20 Â 0.20 mm
Data collection
Bruker X8 APEXII diffractometer Absorption correction: multi-scan (SADABS; Sheldrick, 1996) Table 1 Hydrogen-bond geometry (Å , ).
Symmetry code: (i) x; y þ 1; z.
Data collection: APEX2 (Bruker, 2008); cell refinement: SAINT (Bruker, 2008); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: X-SEED (Barbour, 2001); software used to prepare material for publication: publCIF (Westrip, 2010).
supplementary materials
sup-1 Acta Cryst. (2010) . E66, o2843 [ doi:10.1107/S1600536810040328 ] 4-(1,3-Benzothiazol-2-yl)-5-methyl-2-phenyl-1-propynyl-1H-pyrazol-3(2H)-one I. Chakib, A. Zerzouf, H. Zouihri, E. M. Essassi and S. W. Ng Comment (E)-4-(2,3-Dihydro-1,3-benzothiazol-2-ylidene)-3-methyl-1-phenyl-1H-pyrazol-5(4H)-one is an amine that can under a nucleophilic substitution with organo bromides to form 2-substituted derivatives if tetra-n-butyl ammonium bromide is used as catalyst. In this study, the compound is reacted with propargyl bromide to yield the title compound (Scheme I, Fig. 1 ).
Experimental
To a solution of (E)-4-(2,3-dihydro-1,3-benzothiazol-2-ylidene)-3-methyl-1-phenyl-1H-pyrazol-5(4H)-one (1 g, 3.25 mmol) in DMF (50 ml), was added sodium carbonate (2.5 g, 23 mmol), tetra-n-butyl ammonium bromide (0.15 g, 1 mmol) and propargyl bromide (5.5 g, 46 mmol). The mixture was stirred for 24 h at room temperature. The solid material was removed by filtration and the solution was evaporated under reduced. The residue was washed with dichloromethane and hexane, and the recrystallized from ethanol to afford the title compound as yellow crystals.
Refinement
Carbon-bound H-atoms were placed in calculated positions (C-H 0.93-0.97 Å) and were included in the refinement in the riding model approximation, with U(H) set to 1.2-1.5U eq (C). 
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